Guidelines & Requirements
a. To submit a manuscript click here.
2. FILE TYPES
a. Manuscripts: Title page, Abstract, Manuscript body, References, Tables, Figures and Figure legends. All of these sections should be included in one document. Please submit in a Word document. If you encounter any issues uploading your document, please e-mail us at email@example.com.
b. Tables: Place each table under a sub-titled section at the end of the manuscript after the References.
c. Figures: Figures and/or pictures after tables at the end of your manuscript (preferably a high resolution file).
3. ORGANIZATION & STYLE OF PRESENTATION
a. Manuscripts must be written using American (US) English. Authors whose native language is not English are recommended to seek the advice of a native English speaker, before submitting their manuscripts.
b. Manuscripts should be prepared with 1” wide margins on all sides, double spaced throughout (including the abstract, footnotes and references) and 12 point font size (Times New Roman or Arial).
c. Every page of the manuscript, including the title page, references, tables, etc., should be numbered. However, in the text no reference should be made to page numbers; if necessary, one may refer to sections.
d. Avoid the excessive use of italics and bold face. Headings and subheadings should be numbered and typed on a separate line, without indentation.
e. Manuscripts should be organized in the following order:
i. Title page
iii. Body of manuscript (divided by subheadings)
v. Disclosure Statements
viii. Figure legends
ix. Figures (Submit separately as high resolution TIF files)
4. TITLE PAGE
a. Title should be clear, descriptive and concise but informative. Authors should include all information (key words) in the title that will make electronic retrieval of the article both sensitive and specific.
b. Short running title should be up to 40 characters.
c. Name(s) of author(s), should include both initial and surnames and should indicate the corresponding author’s full affiliation(s) footnoted alphabetically directly beneath author names. This should also indicate address of author(s), if different from affiliation.
d. Complete address of corresponding author, including tel. no., fax no. and e-mail address.
e. Include three suggested reviewers along with their affiliations and e-mail addresses.
a. Clear, descriptive, self-explanatory and no greater than 250 words.
b. Structured to include the following subtitles in: Background, Methods, Results, and Conclusions. The aim of the study should be stated in the Background section of the abstract.
d. Abbreviations: Except for units of measurement, abbreviations are strongly discouraged. The first time an abbreviation appears, it should be preceded by the words for which it stands.
e. Suitable for publication in abstracting services.
6. MANUSCRIPT BODY
a. All aspects of the manuscript, including the formatting of tables, illustrations, and references and grammar, punctuation, usage, and scientific writing style, should be prepared according to the most current AMA Manual of Style (http://www.amamanualofstyle.com).
b. Author Listing. All authors’ names should be listed in their entirety, and should include institutional/professional affiliations and degrees held.
c. Leave a single space at the end of each sentence. Do not use bold face for emphasis within text. Utilize a comma before the final “and” or “or” in a list of items.
d. Write out the numbers one through ten unless they are used as a unit of measurement, or are in figures and tables.
e. Do not use the automated features of your software, such as hyphenation, endnotes, headers, or footers (especially for references). You may use page numbering.
a. Contributors are those who provided general support but do not meet the criteria for authorship. Examples include a person who offered technical help, writing assistance, offered guidance/direction, and other broad-spectrum support.
b. Financial and material support should be stated in a separate section immediately following this one.
8. DISCLOSURE STATEMENTS
a. FINANCIAL DISCLOSURE STATEMENT
JNPM requires all authors to disclose any potential or actual interests relevant to the topic(s) discussed in submitted manuscripts. This policy should not prevent authors with financial or other interests from publishing their research. The journal’s intent is to provide reviewers and readers with full disclosure to ensure scientific integrity. Disclosures will be shared with reviewers and will be published with accepted articles. If no potential or actual interests are disclosed, a statement to that effect will be published.
b. HUMAN RESEARCH STATEMENT
Any information that could reveal the identity of a patient or study participant should not be included unless this information is essential for scientific purposes and written informed consent is provided. If informed consent was obtained, the authors must state such in the manuscript. When informed consent is given, the parent or legal guardian must be provided a copy of the manuscript to be published before providing consent. Authors are required to affirm that research involving human subjects submitted to the journal was conducted in accordance with the ethical standards of all applicable national and institutional committees and the World Medical Association’s Helsinki Declaration.
c. ANIMAL RESEARCH STATEMENT
When research involves animal subjects, authors must affirm that the submitted study was conducted in accordance with relevant institutional and national guidelines for the care and use of laboratory and other animals.
d. OTHER DISCLOSURE or DISCLAIMER STATEMENT(S)
List source(s) of support in the form of grants, equipment, drugs, or all of these.
State disclaimers, if any.
a. References must be formatted to the Vancouver style guidelines in accordance with the "International Committee of Medical Journal Editors (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals:
b. Journal titles are abbreviated according to the style used in the PubMed database; full journal name abbreviations are found under the NLM Catalog Tools in the Journals in NCBI Databases.
i. Joutnals: http://www.ncbi.nlm.nih.gov/nlmcatalog/journals
ii. Journal Abbreviations: http://www.ncbi.nlm.nih.gov/sites/entrez?db=journals
c. An "in-text citation” tag point to the cited source in the reference section.Citations within the text are identified with a number in brackets; it is placed before any colons, semi-colons, commas and periods.
i. Example: Smith argued that ... .
d. References are numbered consecutively in the order they are first used in the text. The full citations will be included in the Reference section in the manuscript, with numbers identifying each corresponding reference.
e. When multiple references are cited together, use a hyphen to indicate a series of inclusive numbers. Use commas to indicate a series of non-inclusive numbers. Citations [4,5,6,7,14,19] are abbreviated to [4-7,14,19].
i. Example: Multiple clinical trials [4-6,9] show…
f. The original number used for a reference is reused each time the reference is cited.
g. Numbered references to personal communications, unpublished data, or manuscripts either “in preparation” or “submitted for publication” are unacceptable. If essential, such material can be incorporated at the appropriate place in the text.
h. Example Elements of References/Citations:
1. Journal Article: Many medical journals carry continuous pagination throughout a volume; thus the month and issue number may be omitted.
a) Standard one-six authors: Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002;347:284-7.
b) More than six authors - List the first three authors followed by et al.: Rose ME, Huerbin MB, Melick J, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res 2002; 935:40-6.
a) Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension 2002;40:679-86.
3. Authors and organization
a) Margulies EH, Blanchette M, Haussler D, Green ED; NISC Comparative Sequencing Program. Identification and characterization of multi-species conserved sequences. Genome Res 2003:2507-18.
4. Article published electronically ahead of the print version
a) Standard: Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood 2002 Nov 15;100:3828-31. Epub 2002 Jul 5.
b) No Date: O’Leary C. Vitamin C does little to prevent winter cold. The West Australian Epub 2005.
c) In press or Forthcoming: Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature of balancing selection in Arabidopsis. Proc Natl Acad Sci U S A, Forthcoming 2002.
5. Unidentifiable items
a) No author: 21st century heart solution may have a sting in the tail. BMJ 2002;325:184.
b) Article not in English: Ellingsen AE, Wilhelmsen I. Sykdomsangst blant medisin- og jusstudenter. Tidsskr Nor Laegeforen 2002;122:785-7. Norwegian.
c) Optional translation of article title (MEDLINE/PubMed practice): Ellingsen AE, Wilhelmsen I. [Disease anxiety among medical students and law students]. Tidsskr Nor Laegeforen 2002;122:785-7. Norwegian.
6. Journal article on the Internet
a) Internet cited: Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [Internet] 2002 Jun [cited 2002 Aug 12];102:[about 1 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htmArticle
b) Medium not cited: Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs. 2002 Jun [cited 2002 Aug 12];102:[about 1 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htmArticle
8. Pagination / source / citation variations
a) Document number: Williams JS, Brown SM, Conlin PR. Videos in clinical medicine. Blood-pressure measurement. N Engl J Med 2009 Jan 29;360:e6. PubMed PMID: 19179309.
b) Digital Object Identifier (DOI): Zhang M, Holman CD, Price SD, Sanfilippo FM, Preen DB, Bulsara MK. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009 Jan 7;338:a2752. doi: 10.1136/bmj.a2752. PubMed PMID: 19129307; PubMed Central PMCID: PMC2615549.
c) Publisher item identifier (pii): Tegnell A, Dillner J, Andrae B. Introduction of human papillomavirus (HPV) vaccination in Sweden. Euro Surveill 2009 Feb 12;14. pii: 19119. PubMed PMID: 19215721.
d) Issue with no volume: Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop 2002;401:230-8.
e) No volume or issue: Outreach: bringing HIV-positive individuals into care. HRSA Careaction 2002:1-6.
f) Roman numerals: Chadwick R, Schuklenk U. The politics of ethical consensus finding. Bioethics 2002;16:iii-v.
g) Bracketed medium example I: Tor M, Turker H. International approaches to the prescription of long-term oxygen therapy [letter]. Eur Respir J. 2002;20:242.
h) Bracketed medium example II: Lofwall MR, Strain EC, Brooner RK, Kindbom KA, Bigelow GE. Characteristics of older methadone maintenance (MM) patients [abstract]. Drug Alcohol Depend 2002;66 Suppl 1:S105.
9. Articles with corrections/errors
a) Full Retraction: Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry 2002;63:169. Retraction of: Feifel D, Moutier CY, Perry W. J Clin Psychiatry 2000;61:909-11.
b) Partial retraction: Starkman JS, Wolder CE, Gomelsky A, Scarpero HM, Dmochowski RR. Voiding dysfunction after removal of eroded slings. J Urol 2006 Dec;176:2749. Partial retraction of: Starkman JS, Wolter C, Gomelsky A, Scarpero HM, Dmochowski RR. J Urol 2006 Sep;176:1040-4.
c) Republished with corrections: Mansharamani M, Chilton BS. The reproductive importance of P-type ATPases. Mol Cell Endocrinol 2002;188:22-5. Corrected and republished from: Mol Cell Endocrinol 2001;183:123-6.
d) Published erratum: Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther 2000;22(10):1151-68; discussion 1149-50. Erratum in: Clin Ther 2001;23:309.
10. Books, Monographs, etc.
a. Personal author(s): Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.
b. Editor(s), compiler(s) as author: Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.
c. Author(s) and editor(s): Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed. Wieczorek RR, editor. White Plains (NY): March of Dimes Education Services; 2001.
d. Organization (ex I): Advanced Life Support Group. Acute medical emergencies: the practical approach. London: BMJ Books; 2001. 454 p.
e. Organizations (ex II): American Occupational Therapy Association, Ad Hoc Committee on Occupational Therapy Manpower. Occupational therapy manpower: a plan for progress. Rockville (MD): The Association; 1985 Apr. 84 p.
f. Organizations (ex III): National Lawyer's Guild AIDs Network (US); National Gay Rights Advocates (US). AIDS practice manual: a legal and educational guide. 2nd ed. San Francisco: The Network; 1988.
g. Chapter in a book: Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
a. Provide tables at the end of the manuscript on a separate pages (page breaks) before any figures.
b. Number each table only as Table 1, Table 2, Table 3 and etc.
c. Refer to all included tables within the text in parenthesis.
d. Each table should have a brief and self-explanatory title.
e. Column headings should be brief, but sufficiently explanatory.
f. Standard abbreviations of units of measurement should be added between parentheses.
g. Vertical lines should not be used to separate columns. Instead, leave extra space in between.
h. Attempt to avoid footnotes; however, any abbreviations or any explanations essential to the understanding of the table should be noted in footnotes directly beneath the corresponding table.
11. FIGURE GUIDELINES
a. FIGURE LEGENDS [Provide each figure(s) at the end of the manuscript after the tables section in high resolution. Each figure should be on a separate page]
i. Provide all figures’ complete titles here (corresponding with the respective figure(s)). Figure titles should not be embedded in the figure(s) itself.
. ii. Indicate all figure legends, keys and/or footnotes here (corresponding to the respective figure ).
iii. Refer to all figure(s) in-context within the body of the manuscript using parenthesis at the end of the statement.
b. FIGURE(S) [Provide each figure(s) at the end of the manuscript in high resolution]
i. Do not include the actual figure itself, within the body of the manuscript. Figure(s) should be included after the figure(s) title and legend at the end of the manuscript. All figure(s) should start on a separate page.
ii. Do not add complete titles to actual figure; title each only as: Figure 1, Figure 2, Figure 3 and etc.
iii. Do not add legends or keys to the actual figure.
c. FIGURE(S) STYLE [Format figures according to the exact style utilized in JNPM]
i. Utilize minimal text, numbers and wording. Do NOT use gridlines or display the figure’s title, legends or other footnotes (these are included within the manuscript in the last section under “Figure Legends”.
ii. Axes should reflect as thick bold lines, axes labels’ font style should be Arial bolded at size 14; axes numbers should also be Arial bolded but at size 12.
iii. Differentiate between categories in the visualize demonstration using an uncluttered and easily distinguished formats; employ the colors black, white, and grey for legend purposes. For figures with many legends, utilize different types of dotted lines and 2-colored or checkered bars.
iv. Color figures may be included, provided the cost of their reproduction is paid for by the author.
v. For examples, please refer to figures published in previous JNPM Issues.
a. Authors submitting a manuscript do so on the understanding that they have read and agreed to the terms of the IOS Press Author Copyright Agreement.
b. A suitable acknowledgement of any borrowed material must always be made.
c. Material in unpublished letters and manuscripts are protected and must not be published unless permission has been obtained.
d. Submission of a paper will be interpreted as a statement that the author has obtained all the necessary permission.
e. Quoting from other publications:
i. When quoting from someone else's work or when considering reproducing figures or tables from a book or journal article, an author should make sure that he is not infringing a copyright.
ii. Although general quote from other published works are permissible, substantial extracts, reproduced tables/plates/figures require obtained permission from the holder of the copyright.
iii. If the copyright holder is not the author of the quoted or reproduced material, it is recommended that the permission of the author should also be sought.
13. PROOFS & PURCHASES
a. The corresponding author will receive a PDF proof and be asked to carefully check this proof for final approval (the publisher will execute a cursory check only).
b. Corrections other than printer's errors, however, should be avoided. Costs arising from such corrections will be charged to the authors.
14. ORDERING REPRINTS & SUBSCRIPTIONS
a. The corresponding author of a contribution to the journal is entitled to receive 1 copy of the journal free of charge, unless otherwise stated.
b. Free copies will not be provided for conference proceedings and abstract issues.
c. An order form for reprints, additional journal copies or a PDF file will be provided along with the PDF proof.
d. If you wish to order reprints of an earlier published article, please contact the publisher for a quotation. IOS Press, Fax: +31 20 6870039; E-mail:firstname.lastname@example.org
e. An author is entitled to 25 % discount on IOS Press books. See Author's discount (25%) on all IOS Press book publications.